BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24040448)

  • 1. Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).
    Agaimy A; Otto C; Braun A; Geddert H; Schaefer IM; Haller F
    Int J Clin Exp Pathol; 2013; 6(9):1839-46. PubMed ID: 24040448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoid epithelioid gastrointestinal stromal tumor harboring an unreported PDGFRA mutation: report of a case and review of the literature.
    Tajima S; Ohata A; Koda K; Maruyama Y
    Int J Clin Exp Pathol; 2015; 8(5):5821-9. PubMed ID: 26191304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDGFRA Immunohistochemistry Predicts PDGFRA Mutations in Gastrointestinal Stromal Tumors.
    Papke DJ; Forgó E; Charville GW; Hornick JL
    Am J Surg Pathol; 2022 Jan; 46(1):3-10. PubMed ID: 33859072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance of mutational status in prognosis and therapy of GIST].
    Comandone A; Boglione A
    Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
    Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
    Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
    Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
    Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
    Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
    Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
    Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelioid/mixed phenotype in gastrointestinal stromal tumors with KIT mutation from the stomach is associated with accelerated passage of late phases of the cell cycle and shorter disease-free survival.
    Haller F; Cortis J; Helfrich J; Cameron S; Schüler P; Schwager S; Gunawan B; Füzesi L; Agaimy A
    Mod Pathol; 2011 Feb; 24(2):248-55. PubMed ID: 20834236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy].
    Coindre JM; Emile JF; Monges G; Ranchère-Vince D; Scoazec JY
    Ann Pathol; 2005 Oct; 25(5):358-85; quiz 357. PubMed ID: 16498290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.
    Miettinen M; Felisiak-Golabek A; Wang Z; Inaguma S; Lasota J
    Am J Surg Pathol; 2017 May; 41(5):577-585. PubMed ID: 28288036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site.
    Wasag B; Debiec-Rychter M; Pauwels P; Stul M; Vranckx H; Oosterom AV; Hagemeijer A; Sciot R
    Mod Pathol; 2004 Aug; 17(8):889-94. PubMed ID: 15154005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological characteristics of gastrointestinal stromal tumours with PDGFRA mutations.
    Kwon JE; Kang HJ; Kim SH; Lee YC; Hyung WJ; Noh SH; Kim NK; Kim H
    Pathology; 2009; 41(6):544-54. PubMed ID: 19900103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors.
    Shen YY; Ma XL; Wang M; Zhuang C; Ni B; Tu L; Liu Q; Zhao WY; Cao H
    Cancer Med; 2020 Sep; 9(18):6485-6496. PubMed ID: 32697050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumors (GISTs): role of CD 117 and PDGFRA Golgi-like staining pattern in the recognition of mutational status.
    Jaramillo S; Ríos-Moreno MJ; Hernández A; Amérigo J; Trigo-Sánchez I; González-Cámpora R
    Rev Esp Enferm Dig; 2012 Mar; 104(3):128-33. PubMed ID: 22449154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
    Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
    J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
    Miettinen M; Lasota J
    Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.
    Medeiros F; Corless CL; Duensing A; Hornick JL; Oliveira AM; Heinrich MC; Fletcher JA; Fletcher CD
    Am J Surg Pathol; 2004 Jul; 28(7):889-94. PubMed ID: 15223958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
    Lasota J; Miettinen M
    Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.